E 757
Pill imprint E 757 has been identified as Sulfadiazine 500 mg.
Sulfadiazine is used in the treatment of toxoplasmosis, prophylaxis; rheumatic fever prophylaxis; toxoplasmosis and belongs to the drug class sulfonamides. Risk cannot be ruled out during pregnancy.
Sulfadiazine 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Sulfadiazine Images
- Imprint:
-
E 757
- Strength:
- 500 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
docusate sodium
microcrystalline cellulose
povidone
sodium benzoate
sodium starch glycolate type A potato
stearic acid
- Drug Class:
- Sulfonamides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0757
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68258-9056 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More Sulfadiazine resources
- Sulfadiazine (Wolters Kluwer)
- sulfadiazine (Cerner Multum)
- sulfadiazine (Micromedex) - Includes Dosage Information
- Sulfadiazine (AHFS DI)
- Sulfadiazine (FDA)
- Sulfadiazine (Wolters Kluwer)


